Big Pharma's AI arms race intensifies as Bristol Myers Squibb hands Anthropic the keys to the enterprise 19:07, 20 May 2026
Jack Dorsey to cut Block management layers to two or three to speed AI-driven change 19:03, 20 May 2026
Adsure Services plans to build specialist professional services firms around its proprietary AI 15:42, 20 May 2026
Bloomsbury upgrades 2026/27 profit expectations after strong pre-orders as A&P drives recovery 15:30, 20 May 2026
MedPal AI launches New Health sub-brand for GLP-1s and peptides with £1.3m marketing push 08:42, 20 May 2026
M&S says profit growth to resume after adjusted pre-tax profit falls to £671.4m in year to 28 March 08:31, 20 May 2026
Cranswick lifts adjusted pre-tax profit and increases dividend after record investment 15:50, 19 May 2026
Caspian Sunrise clears anti‑monopoly hurdle for Kazikhan and secures four new BNG well permits 11:43, 18 May 2026
Stockbroker sticks with a Buy on Advanced Medical Solutions after suitor slips away 11:30, 18 May 2026
Eco Atlantic secures court approval to acquire JHI and gain 35% interest in Falklands PL001 09:25, 18 May 2026
Predator Oil & Gas raises £3m to deepen Snowcap‑3 and progress Corrib South workstream 09:04, 18 May 2026
ValiRx raises up to £1.155m to fund McGill in‑licence, Cytolytix preclinical work and animal‑health expansion 09:00, 18 May 2026
Anglo American agrees sale of Australian steelmaking coal assets for up to US$3.875bn 08:29, 18 May 2026
Union Jack Oil's Crossroads well hits multiple hydrocarbon zones, testing set for mid‑June 09:42, 15 May 2026
Future H1 revenue and earnings fall as programmatic advertising and affiliate marketing hit 09:20, 15 May 2026
AstraZeneca says Imfinzi plus enfortumab vedotin improves survival in muscle‑invasive bladder cancer 08:51, 15 May 2026
Spirax Group sticks to guidance as first four months land in line with expectations 10:00, 13 May 2026
Great Southern Copper confirms porphyry-style results at Piedras Blancas, starts drilling at Artemisa North 09:19, 13 May 2026
IP Group's Enterprise Therapeutics hits primary endpoint in Phase 2 cystic fibrosis trial 18:55, 12 May 2026
Market reports Daily reports The Premarket Brief London LIVE Small Caps Today Sector reports Mining Today Oil & Gas Today Health & Bio Today Tech Today
Energy & Resources Topics Oil & Gas Mining & Metals Renewables Nuclear Top Stocks AAL Anglo American ANTO Antofagasta FRES Fresnillo EDV Endeavour Mining GGP Greatland Gold
Financials Topics Banks Insurance Asset Management Fintech & Payments REITs & Property Top Stocks BARC Barclays HSBA HSBC LLOY Lloyds NWG NatWest AV. Aviva PRU Prudential
Technology Topics Software & SaaS Semiconductors AI & Machine Learning Cybersecurity Top Stocks SGE Sage Group RPI Raspberry Pi KNOS Kainos SCT Softcat
Healthcare Topics Pharma Biotech Medtech Healthcare Services Top Stocks AZN AstraZeneca GSK GSK SN. Smith & Nephew HIK Hikma
Industrials Topics Aerospace & Defence Construction Engineering Transport & Logistics Top Stocks BA. BAE Systems RR. Rolls-Royce BAB Babcock QQ. QinetiQ CHG Chemring
Consumer Topics Retail Food & Beverage Travel & Leisure Media & Entertainment Top Stocks DGE Diageo ULVR Unilever TSCO Tesco NXT Next
